Bitopic ligands: all-in-one orthosteric and allosteric

Area of Science:

• Pharmacology
• Molecular Biology
• Biochemistry

Background:

• G-protein-coupled receptors (GPCRs) are crucial cell surface receptors involved in numerous physiological processes.
• Ligands typically bind to the orthosteric site, the primary active site for natural agonists.
• The development of allosteric ligands expanded the therapeutic potential of targeting GPCRs.

Purpose of the Study:

• To review the evolution of ligand-binding strategies for G-protein-coupled receptors.
• To highlight the significance of allosteric and bitopic ligands in GPCR drug discovery.
• To provide an overview of current advancements in modulating GPCR activity.

Main Methods:

• Literature review of G-protein-coupled receptor ligand research.
• Analysis of binding site classifications: orthosteric, allosteric, and bitopic.
• Synthesis of findings on the impact of different ligand types on receptor function.

Main Results:

• Classical synthetic ligands, like natural ones, primarily target the orthosteric binding site.
• The discovery of allosteric ligands significantly broadened the scope of GPCR targeting.
• Bitopic ligands, a recent innovation, simultaneously interact with both orthosteric and allosteric sites.

Conclusions:

• Ligand design for GPCRs has evolved from targeting single sites to dual-site engagement.
• Bitopic ligands offer novel opportunities for precise control over GPCR signaling pathways.
• Understanding these diverse ligand-receptor interactions is key for developing next-generation therapeutics.